📰 Alchemab News
Alchemab News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Alchemab. Real-time updates on events, politics, business and more.
March 22, 2022
Alchemab Therapeutics, a biotechnology company focused on the discovery and development of naturally-occurring protective antibodies and immune repertoire-based patient stratification tools, has been
May 5, 2021
Proof-of-concept immuno-oncology collaboration with AstraZeneca to build understanding of prostate cancer Alchemab's advanced analytics to be used to analyse patient immune responses, identify
May 5, 2021
AstraZeneca (AZN) is collaborating with biotech company Alchemab on prostate cancer research. The two companies will work on a proof-of-concept study to develop insights into prostate cancer. The collaboration will make use of Alchemab’s drug discovery platform to identify disease biomarkers that can help in developing therapeutics based on novel antibodies. Alchemab CSO, Dr. Jane Osbourn said, “Our collaboration with AstraZeneca is a great opportunity to showcase Alchemab’s...
March 16, 2021
Alchemab and Medicines Discovery Catapult to develop landmark novel antibody therapy for Huntingtons disease Alchemab using unique approach to explore adaptive immunity identifying naturally protective antibodies in resilient patients to specific diseases Innovate UK Grant to support the finding of a disease-modifying therapy for Huntingtons disease (HD), a degenerative disease with no cure and no therapies to prevent progression Alchemab is working in collaboration with Medicines Discovery Cat...